Our findings could not rule out that the hypersensitivity of KMT2D-mutant HNSCC cells to PARP inhibitors was due to the defects in other DNA damage repair mechanisms by the inhibition of ATR, BRCA1 and POLQ. This evidence concerns the gene BRCA1 and head and neck squamous cell carcinoma.